Seed Round - NeoImmune
Investment Firm
Overview
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.
Announced Date
Nov 25, 2021
Funding Type
Seed
Highlights
Location
Asia
Social
Participant Investors
1
| Investor Name |
|---|
 Kindstar Global (Beijing) Medicine Technology |
Round Details and Background
NeoImmune raised $4697041 on 2021-11-25 in Seed Round
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 25, 2021 |  Seed Round - NeoImmune | 5 | - | 4.7M |
Recent Activity
There is no recent news or activity for this profile.